Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

220: An Interview With Dr. Jaime Moore on Obesity Medications and Neuromuscular Disease

 April 13, 2026

Rare Disease Audio

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jaime Moore, MD, about weight loss drugs–specifically the role of GLP-1 receptor agonists in treating children with neuromuscula

OtherMetabolic & GLP-1Read full story

Post navigation

Revolution rises 40% as pancreatic cancer drug doubles survival →
← Allogene stock sails after CAR T clears residual lymphoma in early data cut

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com